CapsoVision CV Q1 2026 Earnings EPS Miss Raises Concerns Amid Operational Uncertainty ASIX Q1 2026 Earnings Miss on EPS Stock Rises Despite Weakness NervGen Pharma Q3 2025 Earnings Narrowed Loss Meets Estimates But Stock Plunges 43 LLYVA Q4 2025 Earnings EPS Misses Estimates by a Narrow Margin Insperity Q1 2026 Earnings EPS Surpasses Estimates by 511 GCBC Q2 2025 Earnings Solid EPS of 044 Drives Modest Stock Uptick